dacarbazine/doxorubicin/vinblastine (AVD)

From Aaushi

Jump to navigation Jump to search

^[1]

Indications

antineoplastic combination for treatment of Hodgkin's disease

* for use in combination with nivolumab

More general terms

antineoplastic combination (combination chemotherapy)

Additional terms

Hodgkin's disease (Hodgkin's lymphoma)

Components

References

↑ Rutherford SC et al. Nivolumab-AVD versus brentuximab vedotin-AVD in older patients with advanced-stage classic Hodgkin lymphoma enrolled on S1826. J Clin Oncol 2025 Jun 16; [e-pub]. PMID: https://pubmed.ncbi.nlm.nih.gov/40523203 https://ascopubs.org/doi/10.1200/JCO-25-00204

Retrieved from "https://aaushi.info/w/index.php?title=A59285&oldid=1268144"

↑ Back to top